These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38004723)

  • 1. Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy.
    Equestre M; Marcantonio C; Marascio N; Centofanti F; Martina A; Simeoni M; Suffredini E; La Rosa G; Bonanno Ferraro G; Mancini P; Veneri C; Matera G; Quirino A; Costantino A; Taffon S; Tritarelli E; Campanella C; Pisani G; Nisini R; Spada E; Verde P; Ciccaglione AR; Bruni R
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tool for the cheap and rapid screening of SARS-CoV-2 variants of concern (VoCs) by Sanger sequencing.
    Burgos G; Ambuludí A; ; Morales-Jadán D; Garcia-Bereguiain MA; Muslin C; Armijos-Jaramillo V
    Microbiol Spectr; 2023 Sep; 11(5):e0506422. PubMed ID: 37676038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution.
    Liotti FM; De Maio F; Ippoliti C; Santarelli G; Monzo FR; Sali M; Santangelo R; Ceccherini-Silberstein F; Sanguinetti M; Posteraro B
    Microbiol Spectr; 2022 Dec; 10(6):e0292222. PubMed ID: 36409091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo.
    Ntagereka PB; Oyola SO; Baenyi SP; Rono GK; Birindwa AB; Shukuru DW; Baharanyi TC; Kashosi TM; Buhendwa JC; Bisimwa PB; Kusinza AB; Basengere RA; Mukwege D
    Int J Infect Dis; 2022 Sep; 122():136-143. PubMed ID: 35598737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Molecular Evolution: A Focus on Omicron Variants in Umbria, Italy.
    Bicchieraro G; Ciurnelli R; Graziani A; Wong AYW; Camilloni B; Mencacci A; Spaccapelo R
    Microorganisms; 2024 Jun; 12(7):. PubMed ID: 39065097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of a new strategy for the identification of SARS-CoV-2 variants by sequencing the spike gene by Sanger].
    Murillo E; Palacio-Rua K; Afanador-Ayala C; García-Correa JF; Zuluaga AF
    Enferm Infecc Microbiol Clin; 2023 May; 41(5):284-289. PubMed ID: 35602577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Despite low viral titer in saliva samples, Sanger-based SARS-CoV-2 spike gene sequencing is highly applicable for the variant identification.
    Ko K; Takahashi K; Ito N; Sugiyama A; Nagashima S; Miwata K; Kitahara Y; Okimoto M; Ouoba S; Akuffo GA; E B; Akita T; Takafuta T; Tanaka J
    BMC Med Genomics; 2023 Aug; 16(1):199. PubMed ID: 37620887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors.
    Takashita E; Fujisaki S; Morita H; Nagata S; Miura H; Nagashima M; Watanabe S; Takeda M; Kawaoka Y; Hasegawa H
    Antiviral Res; 2023 Aug; 216():105671. PubMed ID: 37451629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic.
    Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD
    Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Variants of Concern: Presumptive Identification via Sanger Sequencing Analysis of the Receptor Binding Domain (RBD) Region of the
    Rodrigues GM; Volpato FCZ; Wink PL; Paiva RM; Barth AL; de-Paris F
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a new strategy for the identification of SARS-CoV-2 variants by sequencing the spike gene by Sanger.
    Murillo E; Palacio-Rua K; Afanador-Ayala C; García-Correa JF; Zuluaga AF
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 May; 41(5):284-289. PubMed ID: 37144832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
    Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
    J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients.
    Lombardo D; Musolino C; Chines V; Caminiti G; Palermo C; Cacciola I; Raffa G; Pollicino T
    Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38276171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.
    Islam MA; Shahi S; Marzan AA; Amin MR; Hasan MN; Hoque MN; Ghosh A; Barua A; Khan A; Dhama K; Chakraborty C; Bhattacharya P; Wei DQ
    Front Pharmacol; 2023; 14():1090717. PubMed ID: 36825152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.